Neble George R sold $61K of EVER

Neble George R sold 2,456 shares of EverQuote, Inc. (EVER) at $24.64 on 2026-08-19 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Neble George R
Published Aug 21, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 21, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Bearish
medium confidence
Mentioned
$EVER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERBearishLow
01

Why it matters

The disclosed sale is the first public report of this insider transaction, providing new data for investors monitoring insider activity.

02

Market read

Insider sales are monitored for potential signals; this modest sale is unlikely to affect EverQuote's stock price significantly.

03

What to watch

Potential upcoming earnings or strategic announcements that may offset the sale impact.

Relevance 2/10Novelty 4/10Timing: post-market filing

Background

SEC Form 4 filing discloses insider transactions; directors often use 10b5-1 plans for scheduled sales.

Company-level read

Ticker impact

$EVERBearishMedium confidence
Context

Director Neble George R sold 2,456 EVER shares for $60,515.84 via a 10b5-1 plan.

Expected impact

minor downward pressure, likely within normal volatility range

Evidence & confidence

Sale amount is modest relative to insider holdings and overall float; typical for a director's diversification.

Counterpoint

The sale could be routine diversification rather than a lack of confidence.

Key entities

  • EverQuote, Inc.

    Online insurance marketplace listed on NYSE under ticker EVER.

  • Neble George R

    Director of EverQuote who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.